Clinical Trials in Prospera

Targeting the Root Causes of Age-Related Diseases

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Tales of the Molecular Garbage Man

Thu. Feb. 29, 2024

Legal obstacles to longevity biotech and how we might go about removing them?

Thu. Feb. 29, 2024

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Thu. Feb. 29, 2024

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

Clinical Trials in Prospera
|Thu. Feb. 29, 2024
UTC

More videos

See more videos

Non-Profits. The Longevity Pioneers

Foundation Multiomics Models: Driven by Transcriptomics

Longaevus

Clinical Trials in Prospera

Targeting the Root Causes of Age-Related Diseases

Clinical Trials in Prospera

Longaevus

Tales of the Molecular Garbage Man

Legal obstacles to longevity biotech and how we might go about removing them?

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Foundation Multiomics Models: Driven by Transcriptomics

Non-Profits. The Longevity Pioneers

Targeting the Root Causes of Age-Related Diseases

Clinical Trials in Prospera

Longaevus

Tales of the Molecular Garbage Man

Legal obstacles to longevity biotech and how we might go about removing them?

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Foundation Multiomics Models: Driven by Transcriptomics

Non-Profits. The Longevity Pioneers

Non-Profits. The Longevity Pioneers

Foundation Multiomics Models: Driven by Transcriptomics

Longaevus

Clinical Trials in Prospera

Clinical Trials in ProsperaShareDownload|Thu. Feb. 29, 2024UTC

More videos

See more videos

Non-Profits. The Longevity Pioneers

Foundation Multiomics Models: Driven by Transcriptomics

Longaevus

Clinical Trials in Prospera

Targeting the Root Causes of Age-Related Diseases

Clinical Trials in Prospera

Longaevus

Tales of the Molecular Garbage Man

Legal obstacles to longevity biotech and how we might go about removing them?

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Foundation Multiomics Models: Driven by Transcriptomics

Non-Profits. The Longevity Pioneers

Targeting the Root Causes of Age-Related Diseases

Clinical Trials in Prospera

Longaevus

Tales of the Molecular Garbage Man

Legal obstacles to longevity biotech and how we might go about removing them?

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Foundation Multiomics Models: Driven by Transcriptomics

Non-Profits. The Longevity Pioneers

Non-Profits. The Longevity Pioneers

Foundation Multiomics Models: Driven by Transcriptomics

Longaevus

Clinical Trials in Prospera

Clinical Trials in Prospera
|Thu. Feb. 29, 2024
UTC